The Psychotherapy in MDMA-Assisted Psychotherapy
Ioana Alina Cristea, Pim Cuijpers, Joar Øveraas Halvorsen
JAMA Psychiatry November 1, 2024 DOI: 10.1001/jamapsychiatry.2024.2887 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Theoretical or philosophical paper Peer reviewed |
|---|---|
| Intervention | MDMA-assisted psychotherapy |
| Topics | MDMA Psychedelic-assisted therapy |
| Key points | Argues that the psychotherapy component in MDMA-assisted psychotherapy trials for PTSD is a critical but overlooked factor in assessing trial validity. |
Abstract
This Viewpoint discusses the critical yet overlooked role of the psychotherapy component in assessing the validity of the trials of midomafetamine/3,4-methylenedioxymethamphetamine (MDMA)–assisted psychotherapy for posttraumatic stress disorder.